The Lawsuit and the Trial Data Shareholders are suing Novo Nordisk over how the company talked up its next-generation obesity drug CagriSema
Unlike the FDA-approved dosing regimen for GLP-1s, there is no published evidence to support microdosing these medications to achieve weight loss
Instead of judging progress by the scale alone, clinicians may also track waist measurements, blood pressure, glucose markers, energy level, strength, and how clothing fits
Then, twist off the safety cap from the mixing needle when youre ready to mix
Worth knowing: the Returns page describes a 50% refund option for opened bottles with half or more remaining, while the brand's separate General Terms and Conditions state that only unopened, unused products are accepted - the two documents don't agree, so confirm which one applies to your order before you rely on either
A typical retatrutide protocol runs 24 to 48 weeks, with some people continuing indefinitely